TELA Bio (TELA) Tax Provisions (2025 - 2026)
TELA Bio's quarterly Tax Provisions came in at $60000.0 in Q1 2026, up 15.38% year-on-year from $52000.0 in Q1 2025, and up 5900.0% quarter-over-quarter from $1000.0 in Q4 2025.
TELA Bio has reported Tax Provisions for 2 years, with the latest figure at $60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 15.38% year-over-year to $60000.0; the trailing twelve-month figure through Mar 2026 stood at $94000.0 (changed N/A YoY), and the FY2025 full-year result was $86000.0, up 159.72% from the prior year.
- Tax Provisions for Q1 2026 stood at $60000.0, up from $1000.0 in the prior quarter.
- The five-year high for Tax Provisions was $60000.0 in Q1 2026, with the low at $1000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 254.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -51.51 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 70.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 84.20 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Mar 31, 2025 | 52,000.00 |